TITLE

Custom prescriptions

AUTHOR(S)
O'Connor, Patrick G.; Berkowitz, Henry D.; Cohn, Peter F.; Gorman, B. David; Lief, Philip D.; Mishell Jr., Daniel R.; Nichols, Gwen L.; Rigsby, Michael O.; Ryan, Michael E.
PUB. DATE
December 1997
SOURCE
Cortlandt Forum;12/20/97, Vol. 10 Issue 12, p119
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Provides information on where sublingual testosterone tablets can be obtained.
ACCESSION #
113290

 

Related Articles

  • Sustained Anabolic Effects of Long-Term Androgen Administration in Men with AIDS Wasting. Grinspoon, Steven; Corcoran, Collen; Anderson, Ellen; Hubbard, Jane; Stanley, Takara; Basgoz, Nesli; Klibanski, Anne // Clinical Infectious Diseases;3/1/1999, Vol. 28 Issue 3, p634 

    Studies sustained anabolic effects of long-term androgen administration in men with hypogonadism and AIDS wasting. Assessment of nutritional and body composition; Percentages of subjects receiving protease inhibitor therapy at the baseline and months of visits; Development of gynecomastia...

  • Successful Percutaneous Dihydrotestosterone Treatment of Gynecomastia Occurring during Highly Active Antiretroviral Therapy: Four Cases and a Review of the Literature. Benveniste, Olivier; Simon, Anne; Herson, Serge // Clinical Infectious Diseases;9/15/2001, Vol. 33 Issue 6, p891 

    Fourteen cases of gynecomastia occurring during highly active antiretroviral therapy (HAART) have been reported in the literature. To date, no specific therapeutic approach has been proposed, and gynecomastia has usually persisted. We report 4 new cases of HAART-induced gynecomastia that were...

  • Sexual problems of diabetic men. Tattersall, Robert // British Medical Journal (Clinical Research Edition);10/2/1982, Vol. 285 Issue 6346, p911 

    Focuses on the sexual problems of diabetic men. Probability of impotence and the presence of microvascular complications; Necessity for physical examination to assess the presence of diabetic complications or other neurological disorder; Efficacy of testosterone and chorionic gonadotrophin as...

  • CORRECTION.  // JAMA: Journal of the American Medical Association;1/15/2014, Vol. 311 Issue 3, p306 

    A correction to the article "Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stroke in Men With Low Testosterone Levels" that was published in the November 6, 2013 issue is presented.

  • Testosterone for loss of libido. D.R.M. // Cortlandt Forum;02/25/97, Vol. 10 Issue 2, p138 

    Focuses on the effectiveness of testosterone injections or patches in postmenopausal women complaining of fatigue and libido loss despite intake of conjugated estrogens and medroxyprogesterone. Fears of side effects such as facial hair and voice lowering; Effectiveness of testosterone ointment...

  • Short-term, high-dose testosterone treatment fails to reduce adult height in boys with constitutional tall stature. Bettendorf, M.; Heinrich, U. E.; Schönberg, D. K.; Grulich-Henn, J. // European Journal of Pediatrics;1997, Vol. 156 Issue 12, p911 

    Height predictions based on three different methods (Bayley-Pinneau [BP], Tanner-Whitehouse Mark II [TW II], Roche-Wainer-Thissen [RWT]) were compared to adult heights in 19 males with constitutional tall stature previously treated with high-dose testosterone oenanthate for 6 months (group A)...

  • METHYLESTOSTERONE THERAPY FOR HEREDITARY EPISODIC EDEMA (HEREDITARY ANGIONEUROTIC EDEMA). Spaulding, W.B. // Annals of Internal Medicine;Oct60, Vol. 53 Issue 4, p739 

    Studies the efficacy of methyltestosterone therapy in curing hereditary episodic edema or hereditary angioneurotic edema. Manifestations of hereditary episodic edema; Possibility of using testosterone to prevent the attacks of the edema.

  • Pharmacoepidemiology of testosterone prescribing in Australia, 1992--2010. Handelsman, David J. // Medical Journal of Australia;6/4/2012, Vol. 196 Issue 10, p642 

    The article discusses a study on patterns of testosterone prescribing in Australia from January 1992 to December 2010. Researchers found that there has been a ninefold increase in total annual expenditure on testosterone products, according to Pharmaceutical Benefit Scheme (PBS) data....

  • Testosterone up. A case of disease mongering? Katelaris, Annette // Medical Journal of Australia;6/4/2012, Vol. 196 Issue 10, p611 

    An introduction to the journal is presented in which the editor discusses various reports published within the issue including one on changes in the patterns of testosterone prescribing in Australia, one on medical regulatory failures, and one on hepatitis C treatment.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics